Reviva Pharmaceuticals Holdings (RVPH) Long-Term Investments (2018 - 2020)

Reviva Pharmaceuticals Holdings has reported Long-Term Investments for 3 years, with the latest figure at $34.6 million in Q4 2020.

• Quarterly Long-Term Investments fell 47.76% year-over-year to $34.6 million in Q4 2020, while the trailing twelve-month figure through Nov 2020 was $34.6 million (down 47.76% YoY) and the FY2020 annual result came in at $60.9 million, down 6.68% from the prior year.
• Long-Term Investments advanced to $34.6 million in Q4 2020 per RVPH's latest filing, from $34.4 million in the prior quarter.
• Over five years, Long-Term Investments peaked at $66.3 million in Q4 2019 and troughed at $34.2 million in Q2 2020.
• A 3-year average of $55.7 million and a median of $64.7 million in 2018 frame the typical range for Long-Term Investments.
• The sharpest annual moves came in 2019 and 2020: Long-Term Investments rose 2.3% in 2019, then plunged 47.88% in 2020.
• Over 3 years, Long-Term Investments stood at $64.9 million in 2018, then increased by 2.23% to $66.3 million in 2019, then slumped by 47.76% to $34.6 million in 2020.
• According to Business Quant data, Long-Term Investments over the past three periods registered $34.6 million, $34.4 million, and $34.2 million for Q4 2020, Q3 2020, and Q2 2020 respectively.